期刊文献+

尿液PCA3基因检测在前列腺癌诊治中的临床意义 被引量:1

The siqnificance of urine PCA3 .qene in the dia clnosis and treatment of prostate cancer
原文传递
导出
摘要 目的探讨前列腺按摩后尿液中PCA3基因表达在前列腺癌诊断和治疗中的临床应用。方法收集前列腺增生患者34例,前列腺癌24例,取尿液,前列腺癌患者内分泌治疗后重新取尿液,分别离心后取沉淀物,用RT-PCR半定量方法检测PCA3表达情况。结果前列腺增生患者尿液中未找到PCA3基因,前列腺癌患者尿液PCA3基因表达呈阳性,内分泌治疗前后前列腺癌患者尿液PCA3基因表达有显著差异。结论尿液PCA3检测可以作为前列腺癌诊断的一个指标,可以对前列腺癌的治疗进行指导。它作为一种无创性诊断方法具有良好的前景。 Objective To investigate the expression ofPCA3 gene in urine of patients with prostate cancer after prostate massaging. Methods The expression of PCA3 gene was detected by RT-PCR in urine of 24 patients with prostate cancer, 34 patients with benigh prostate hyperplasia and 24 patients with prostate cancer after endocrine therapy. Results No expression of urine PCA3 gene was found in patients with benigh prostate hyperplasia, but positive expression in patients with prostate cancer. The urine PCA3 gene expression had significant difference before and after endocrine therapy. Conclusion Urine PCA3 gene can be used as an index for diagnosis and treatment of prostate cancer.
出处 《中国男科学杂志》 CAS CSCD 2011年第5期11-13,共3页 Chinese Journal of Andrology
关键词 逆转录聚合酶链反应 前列腺肿瘤 尿 reverse transcriptase polymerase chain reaction prostatic neoplasms urine
  • 相关文献

参考文献6

  • 1Freedland S J, Partm AW. Prostate-specific antigen: update 2006. Urology 2006; 67(3): 458-460.
  • 2Catalona WJ, Partin AW, Slawin KM, et al. Use of the percentage of free prostate specific antigen to enhance differentiation of prostate caner from benign prostatic disease;a prospective multicenter clinical trial. JAMA 1998; 279(19): 1542-1547.
  • 3Bussemakers MJ, van Bokhoven A, Verhaegh GW, et al. DD3: a new prostate-specific gene, highly overexpressed m prostate cancer. CancerRes 1999; 59(23): 5975-5979.
  • 4de Kok JB, Verhaegh GW, Roelofs RW, et al. DD3 (PCA3), a very sensitive and specific marker to detect prostate tumors, Cancer Res 2002; 62(9): 2695-2698.
  • 5Tinzl M, Marberger M, Horvath S, et al. DD3PCA3RNA analysis in urine-a new perspective for detecting prostate cancer. Eur Urol 2004; 46(2): 182-186; discussion 187.
  • 6Groskopf J, Aubin SM, Deras IL, et al. APTIMA PCA3 molecular urine test:development of a method to aid in the diagnosis of prostate cancer. Clin Chem 2006; 52(6): 1089-1095.

同被引文献18

  • 1孙继兴,赵刚,杨雅静,等.恶性肿瘤患者血清、胸水、腹水、囊肿液、尿液中胱抑素C和可溶性尿激酶受体水平的测定[J].中国老年医学,2011,31:498.
  • 2Gamagedara S, Gibbons S, Ma Y. Investigation of urinary pteri- dine levels as potential biomarkers for noninvasive diagnosis of cancer[J]. Clin Chim Acta, 2011, 412 (1 -2):120 - 128.
  • 3卿笃桔,龚志军,陈学中.大肠癌患者尿液层粘连蛋白检测及临床意义[J].现代肿瘤学,2008,16(1):60一62.
  • 4Khadjavi A, Barbero G, Destefanis P, et al. Evidence of abnor- mal tyrosine phosphorylated proteins in the urine of patients with bladder cancer: the road toward a new diagnostic tool[ J] ? J Urol,2011,185(5) : 1922 -1929.
  • 5Wu T, Giovannucci E, Welge J, et al. Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening : a meta-analysis [ J ]. Br J Cancer, 2011, 105 ( 1 ) : 65 -73.
  • 6Serizawa RR, Ralfkiaer U, Steven K, et al. Integrated genetic and epigenetic analysis of bladder cancer reveals an additive diag- nostic value of FGFR3 mutations and hypermethylation events [J]. Int J Cancer, 2011, 129(1):78-87.
  • 7Barocas DA, Motley S, Cookson MS, et al. Oxidative stress measured by urine F2-isoprostane level is associated with pros- tate cancer[J]. J Urol, 2011, 185(6) :2102 -2107.
  • 8王一,孙光,刘晓强,等.荧光原位杂交在尿路上皮癌诊断中的应用[J].2011,38(3):148-150.
  • 9Fujita K, Ewing CM, Isaacs WB, et al. Immunomodulatory IL- 18 binding protein is produced by prostate cancer ceils and its levels in urine and serum correlate with tumor status[J]. Int J Cancer, 2011, 129(2) :424 -432.
  • 10张东兵,徐露,燕敏.尿液中的小分子代谢物质检测对胃癌的诊断价值[J].医学临床研究,2009,26(6):966-969. 被引量:3

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部